Sign Up

715 Mitch Daniels Blvd., West Lafayette, IN 47907-2061

View map

Since the passage of the Bayh-Dole Act in 1980, researchers at universities can patent and commercialize their inventions even when the research leading to those inventions received federal funding. The passage of Bayh-Dole is estimated to have led to a ten-fold increase in patent commercialization, and has contributed to more than $1 trillion dollars in GDP growth. Today, however, Bayh-Dole, and all of the scientific and economic benefits it has brought, is under threat: the Biden administration is considering reclaiming ownership of patents in an effort to curb prescription drug prices.


Panelists will discuss the past, present, and future of the Bayh-Dole Act from their perspectives in the policy world of Washington D.C., a private sector firm developing cutting edge pharmaceuticals, and from Purdue University itself. 



Joe Allen- Executive Director, Bayh-Dole Coalition

Brooke Beier, PhD- Senior Vice President of Commericalization, Purdue Research Foundation

Duane Marks- Associate Vice President and Assistant General Patent Counsel- Neuroscience and IP Procurements, Eli Lilly

Event Details